[ST elevation myocardial infarction (STEMI) in patients aged 85 and over. Invasive management versus exclusive
1Service de cardiologie, CHD de Vendée, Les Oudairies, 85000 La Roche-sur-Yon, France.
Insights
Invasive management for ST elevation myocardial infarction (STEMI) in elderly patients (85+) may reduce mortality without increasing complications. This study compared invasive reperfusion versus non-invasive treatment in this high-risk population.
Area of Science:
- Cardiology
- Geriatric Medicine
- Interventional Cardiology
Background:
- ST elevation myocardial infarction (STEMI) poses significant risks for elderly patients.
- The role of invasive management, such as percutaneous coronary intervention (PCI), in this population remains debated.
Purpose of the Study:
- To evaluate the efficacy and safety of invasive management versus non-invasive treatment for STEMI in patients aged 85 and over.
- To compare mortality, morbidity, complications, and loss of independence between the two management strategies.
Main Methods:
- Retrospective single-center study of 118 patients (≥85 years) with STEMI from 2008-2013.
- Patients were divided into invasive (coronary angiogram/fibrinolysis) and non-invasive (exclusive medical treatment) groups.
- Outcomes assessed included mortality, intrahospital complications, and loss of independence.
Main Results:
- The non-invasive group had a higher all-cause mortality rate (45% vs. 28%, P=0.077).
- No significant differences were observed in intrahospital complication rates or loss of independence between groups.
- Advanced age, female gender, history of valvular disease, and delayed primary care were identified as negative prognostic factors.
Conclusions:
- Invasive management of STEMI in elderly patients (≥85 years) appears to reduce one-year mortality.
- This approach does not seem to increase morbidity or loss of independence compared to non-invasive treatment.
Introduction:
Percutaneous coronary intervention (PCI) and/or fibrinolysis for management of an ST elevation myocardial infarction (STEMI) are at high risk in the elderly. Is there any place for an invasive management in this particular population?
Methods:
It is a single-center retrospective study (CHD Vendée, La Roche-sur-Yon) including patients aged 85 and over who had STEMI between January 2008 and December 2013, divided into two groups: coronary angiogram/fibrinolysis ("invasive") versus exclusive medical treatment ("non-invasive"), comparing mortality, morbidity, complications and loss of independence.
Results:
Among the 1373 patients hospitalized for STEMI, 118 (8.6%) were included: 71 (60.2%) underwent an invasive procedure for reperfusion whereas 47 had "non-invasive" management. All cause mortality rate was higher in the "non-invasive" group (28% versus 45%; P=0.077 NS). The identified pejorative criteria are age, female gender, past history of severe valvular disease, and delay for primary care. No difference was found in intrahospital complication rate (23 vs 21; P=0.21) nor in loss of independence.
Conclusion:
The invasive management of STEMI in the elderly may reduce the one-year mortality rate without increasing morbidity.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Mitral Stenosis III: Medical Management
Acute Coronary Syndrome I: Introduction
Endocarditis III: Medical Management
Angina IV: Management
